• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

TIPS for Portal Hypertension in HCC With Tumour Invasion of the Portal Vein Trunk: Anecdote or Promise?

作者信息

Bosch Jaime

机构信息

Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland.

Baveno Cooperation, an EASL Consortium, Switzerland.

出版信息

J Clin Exp Hepatol. 2024 Mar-Apr;14(2):101356. doi: 10.1016/j.jceh.2024.101356. Epub 2024 Feb 1.

DOI:10.1016/j.jceh.2024.101356
PMID:38389700
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10879022/
Abstract
摘要

相似文献

1
TIPS for Portal Hypertension in HCC With Tumour Invasion of the Portal Vein Trunk: Anecdote or Promise?肝癌门静脉主干受肿瘤侵犯时门静脉高压的处理技巧：奇闻轶事还是前景可期？
J Clin Exp Hepatol. 2024 Mar-Apr;14(2):101356. doi: 10.1016/j.jceh.2024.101356. Epub 2024 Feb 1.
2
TIPS plus sequential systemic therapy of advanced HCC patients with tumour thrombus-related symptomatic portal hypertension.TIPS 联合序贯系统治疗伴肿瘤栓子相关症状性门静脉高压的晚期 HCC 患者。
Eur Radiol. 2022 Oct;32(10):6777-6787. doi: 10.1007/s00330-022-08705-7. Epub 2022 Apr 20.
3
Transjugular Intrahepatic Portosystemic Shunt for Advanced Hepatocellular Carcinoma With Main Portal Vein Tumor Thrombus-Related Symptomatic Portal Hypertension.经颈静脉肝内门体分流术治疗伴有门静脉主干肿瘤血栓相关症状性门静脉高压的晚期肝细胞癌
J Clin Exp Hepatol. 2024 Mar-Apr;14(2):101305. doi: 10.1016/j.jceh.2023.101305. Epub 2023 Nov 18.
4
Fully Covered Stent-TIPS for Advanced HCC Patients with Portal Vein Tumor Thrombus-Related Severe Symptomatic Portal Hypertension.全覆膜支架-经颈静脉肝内门体分流术治疗伴有门静脉癌栓相关严重症状性门静脉高压的晚期肝癌患者
J Hepatocell Carcinoma. 2025 Jan 14;12:29-41. doi: 10.2147/JHC.S491153. eCollection 2025.
5
Transjugular Intrahepatic Portosystemic Shunt for Portal Hypertension in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.经颈静脉肝内门体分流术治疗合并门静脉癌栓的肝细胞癌门静脉高压症
Cardiovasc Intervent Radiol. 2017 Sep;40(9):1372-1382. doi: 10.1007/s00270-017-1655-8. Epub 2017 May 9.
6
Investigating the risk factors of hepatocellular carcinoma and survival analysis for cirrhosis after transjugular intrahepatic portosystemic shunt in treating portal hypertension.经颈静脉肝内门体分流术治疗门静脉高压后门静脉高压症患者肝细胞癌的危险因素及生存分析。
J Cancer Res Ther. 2018;14(4):826-832. doi: 10.4103/jcrt.JCRT_930_17.
7
Extent of portal vein tumour thrombosis in patients with hepatocellular carcinoma: The more, the worse?肝细胞癌患者门静脉癌栓的范围：越多，越差？
Liver Int. 2019 Feb;39(2):324-331. doi: 10.1111/liv.13988. Epub 2018 Nov 9.
8
Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.伴有门静脉癌栓的晚期肝细胞癌肝切除术后的生存率
World J Gastroenterol. 2015 Jan 7;21(1):246-53. doi: 10.3748/wjg.v21.i1.246.
9
Transjugular intrahepatic portosystemic shunt for symptomatic portal hypertension in hepatocellular carcinoma with portal vein tumor thrombosis.经颈静脉肝内门体分流术治疗伴有门静脉癌栓的肝细胞癌相关症状性门静脉高压症。
Hepatol Res. 2014 Jun;44(6):621-30. doi: 10.1111/hepr.12162. Epub 2013 Jun 13.
10
Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension.经颈静脉肝内门体分流术联合其他干预措施治疗门静脉高压性肝细胞癌
World J Gastroenterol. 2015 Nov 21;21(43):12439-47. doi: 10.3748/wjg.v21.i43.12439.

本文引用的文献

1
Management of varices but not anticoagulation is associated with improved outcome in patients with HCC and macrovascular tumour invasion.对于合并 HCC 和大血管肿瘤侵犯的患者，管理静脉曲张但不抗凝与改善预后相关。
Cancer Imaging. 2024 Jan 13;24(1):9. doi: 10.1186/s40644-024-00657-z.
2
Transjugular Intrahepatic Portosystemic Shunt for Advanced Hepatocellular Carcinoma With Main Portal Vein Tumor Thrombus-Related Symptomatic Portal Hypertension.经颈静脉肝内门体分流术治疗伴有门静脉主干肿瘤血栓相关症状性门静脉高压的晚期肝细胞癌
J Clin Exp Hepatol. 2024 Mar-Apr;14(2):101305. doi: 10.1016/j.jceh.2023.101305. Epub 2023 Nov 18.
3
AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis.美国肝病研究学会关于肝硬化门静脉高压症和静脉曲张风险分层与管理的实践指南
Hepatology. 2024 May 1;79(5):1180-1211. doi: 10.1097/HEP.0000000000000647. Epub 2023 Oct 23.
4
Role of nonneoplastic PVT in the natural history of patients with cirrhosis and first diagnosis of HCC.非肿瘤性 PVT 在初诊 HCC 肝硬化患者自然病程中的作用。
Hepatology. 2024 Feb 1;79(2):355-367. doi: 10.1097/HEP.0000000000000538. Epub 2023 Jul 17.
5
Portal hypertension and variceal bleeding in patients with liver cancer: Evidence gaps for prevention and management.肝癌患者的门静脉高压症和静脉曲张出血：预防与管理方面的证据空白
Hepatology. 2024 Jan 1;79(1):213-223. doi: 10.1097/HEP.0000000000000291. Epub 2023 Jan 13.
6
Treatment of portal hypertension in patients with HCC in the era of Baveno VII.巴韦诺 VII 时代肝癌患者门静脉高压的治疗
J Hepatol. 2023 Mar;78(3):658-662. doi: 10.1016/j.jhep.2022.11.019. Epub 2022 Nov 30.
7
TIPS plus sequential systemic therapy of advanced HCC patients with tumour thrombus-related symptomatic portal hypertension.TIPS 联合序贯系统治疗伴肿瘤栓子相关症状性门静脉高压的晚期 HCC 患者。
Eur Radiol. 2022 Oct;32(10):6777-6787. doi: 10.1007/s00330-022-08705-7. Epub 2022 Apr 20.
8
Effect of transjugular intrahepatic portosystemic shunt combined with I particle implantation on portal vein tumor thrombus in hepatocellular carcinoma.经颈静脉肝内门体分流术联合碘粒子植入治疗肝细胞癌门静脉癌栓的疗效
Am J Transl Res. 2022 Mar 15;14(3):1838-1848. eCollection 2022.
9
Baveno VII - Renewing consensus in portal hypertension.《巴韦诺 VII 共识：门静脉高压领域的新共识》
J Hepatol. 2022 Apr;76(4):959-974. doi: 10.1016/j.jhep.2021.12.022. Epub 2021 Dec 30.
10
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.BCLC 策略用于预后预测和治疗推荐：2022 年更新版。
J Hepatol. 2022 Mar;76(3):681-693. doi: 10.1016/j.jhep.2021.11.018. Epub 2021 Nov 19.